Ovarian Cancer HRT

14.05.2026 Prof. Dr. Cihan Kaya

HRT Use After Ovarian Cancer – A Comprehensive Guide

What is HRT?

Hormone replacement therapy (HRT) is the replacement of estrogen and progesterone hormones that decrease after menopause. The aim is to reduce menopausal symptoms and improve quality of life.

Is HRT Used After Ovarian Cancer?

HRT use after ovarian cancer is evaluated differently compared to breast and endometrial cancer. Many studies have shown that HRT may be safe in selected patients.

What Do Scientific Data Say?

Studies, especially those conducted after epithelial ovarian cancer, have reported that HRT use does not increase the risk of recurrence and, in some studies, may positively affect survival.

In Which Patients Is It Safer?

HRT is considered safer in patients with early-stage disease, low-risk histology, and completed treatment. It may be considered especially in patients with severe menopausal symptoms.

In Which Situations Should Caution Be Exercised?

More careful evaluation is required in cases of high-risk tumors, presence of residual disease, or hormone-sensitive tumor subtypes.

Estrogen Alone or Combined HRT?

In patients who have had a hysterectomy, estrogen alone can generally be used. However, the decision should be made based on individual risk factors.

Transdermal HRT Preference

Transdermal (through the skin) HRT is often preferred due to its lower risk of thrombosis and stable hormone levels.

Alternative Treatments

Non-hormonal treatments (SSRI/SNRI, gabapentin, lifestyle changes) may be the first option, especially in high-risk patients.

Vaginal Symptoms

Local moisturizers are preferred for vaginal dryness. Low-dose local estrogen can be used with careful evaluation.

Multidisciplinary Approach

The decision regarding HRT must be made after joint evaluation by a gynecologic oncologist and an obstetrician-gynecologist.

Follow-up

Patients initiated on HRT should be regularly monitored and observed carefully for new symptoms or suspicious findings.

Conclusion

After ovarian cancer, HRT can be used safely with appropriate patient selection. A personalized approach is the most important factor.

Tüm Yazılar